Key facts

Financial results (Full-year 2019)

Product Sales

Change at constant exchange rates

Core Earnings per Share

Change at constant exchange rates



SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at . The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
365备用网址APP Cambridge CB2 0AA


Our pipeline

365备用网址APPOur pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

167

projects in our pipeline

7

new molecular entities in our late-stage pipeline

1

new molecular entity approval in the last quarter



Contact us

Investor enquiries

Main Contacts

365备用网址APPThomas Kudsk Larsen

365备用网址APPHenry Wheeler

Oncology

365备用网址APPJosie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Craig Marks

365备用网址APPFinance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

365备用网址APPTom Waldron

Other medicines

Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

365备用网址APPUS general enquiries


  • Annual reports

    365备用网址APPOur Annual Report provides a wide range of information about our global business.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development